SCPH NASDAQ
Burlington, MA 01803
US
scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the advancement of a single-use SmartDose device. Founded in 2013, the company's main operations are based in Burlington, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| SCHAEFFER LEONARD D | U-Tender | 43,104 | — | 2025-10-07 |
| SCHAEFFER LEONARD D | D-Return | 19,750 | $4.11 | 2025-10-07 |
| SCHAEFFER LEONARD D | D-Return | 30,000 | $3.85 | 2025-10-07 |
| SCHAEFFER LEONARD D | D-Return | 16,300 | $4.53 | 2025-10-07 |
| VEITINGER KLAUS R DR | D-Return | 30,000 | $3.85 | 2025-10-07 |